Deepthy Alapati studies the possibility of gene editing within the womb using a technology called CRISPR. This includes targeting genetic issues related to lung disease and metabolic disorders. For example, she has researched how to edit genes that cause fatal conditions in newborns, such as specific lung diseases and high cholesterol, both of which can lead to severe health complications or even death shortly after birth. By delivering gene-editing tools directly into the amniotic fluid at carefully chosen times during pregnancy, her research aims to offer a groundbreaking approach to curing genetic diseases before a baby is born.
Key findings
In a study from 2019, prenatal gene editing in mice with genetic lung disease led to survival rates significantly improved from 0% to 100% at birth.
In another study from 2018, CRISPR was used to edit genes associated with high cholesterol and hereditary tyrosinemia type 1, resulting in one group showing a significant drop in cholesterol levels and survival of mice that otherwise would have died from the disease.
Both studies highlight that gene editing performed before birth can correct genetic mutations, leading to functional improvements in health outcomes for newborns.
Frequently asked questions
Does Dr. Alapati study lung diseases?
Yes, Dr. Alapati researches prenatal gene editing to address genetic lung diseases that can lead to death at birth.
What treatments has Dr. Alapati researched?
She has focused on using CRISPR technology to edit faulty genes associated with several fatal conditions, including lung disease and metabolic disorders.
Is Dr. Alapati's work relevant to genetic disease treatment?
Absolutely, her research offers innovative approaches to prevent or cure genetic diseases before babies are born, potentially saving lives.
Publications in plain English
Administration of Drugs/Gene Products to the Respiratory System: A Historical Perspective of the Use of Inert Liquids.
2022
Frontiers in physiology
Alapati D, Shaffer TH
Plain English This paper looks at how inert liquids have been used over time to support breathing and deliver medications directly to the lungs. It reviews the advantages of using these liquids instead of traditional gas mixtures, highlights their effectiveness in improving lung function, and discusses various studies on their impact on respiratory diseases. This matters because finding better ways to deliver treatment can improve outcomes for patients with breathing problems.
Who this helps: Patients with respiratory diseases.
Biopsychosocial factors associated with complications in patients with frostbite.
2022
Medicine
Endorf FW, Alapati D, Xiong Y, DiGiandomenico C, Rasimas CS +2 more
Plain English This study looked at how factors like homelessness and mental health issues, especially substance use disorders, affect the severity of frostbite injuries and recovery outcomes. Out of 148 patients with frostbite, 40 had to return to the hospital within a year, and those who were homeless or had substance use issues were much more likely to face complications; for instance, 85% of readmitted patients had a substance use disorder. This matters because 18% of frostbite cases led to amputations, highlighting the need for better support and resources for at-risk patients to prevent serious health issues.
Who this helps: This research benefits patients with frostbite, especially those who are homeless or struggling with addiction.
Pulmonary immune cell transcriptome changes in double-hit model of BPD induced by chorioamnionitis and postnatal hyperoxia.
2021
Pediatric research
Shrestha D, Ye GX, Stabley D, Betal SGN, Zhu Y +8 more
Plain English This study focused on preterm infants with bronchopulmonary dysplasia (BPD), a condition that affects their lungs and can lead to long-term breathing problems. Researchers examined how certain early life factors—specifically, inflammation from infections before birth and exposure to high oxygen levels after birth—change the immune cells in the lungs. They found that genes critical for T cell function were significantly reduced, which may make these infants more susceptible to respiratory issues later on.
Who this helps: This helps preterm infants with BPD and their healthcare providers.
Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
2019
Pediatric cardiology
Behere S, Alapati D, McCulloch MA
Plain English This study looked at premature infants diagnosed with bronchopulmonary dysplasia (BPD) to see if early heart imaging and blood tests could predict the later development of high blood pressure in the lungs, known as pulmonary hypertension (PHTN). Out of 37 infants, 9 showed signs of early PHTN, and 4 of those developed late PHTN during follow-up. The findings revealed that infants who eventually had late PHTN were more likely to have higher levels of a heart-related substance in their blood and certain changes in heart structure at the time of their BPD diagnosis.
Who this helps: This helps doctors identify at-risk infants so they can monitor and manage potential complications effectively.
Alapati D, Zacharias WJ, Hartman HA, Rossidis AC, Stratigis JD +12 more
Plain English Researchers developed a way to edit genes in fetal lungs before birth using CRISPR technology, delivering it directly into the amniotic fluid at precisely the right time during pregnancy. In mice with a genetic lung disease that normally kills them at birth, this prenatal gene editing fixed the mutated gene, improved their lung structure, and allowed them to survive. This breakthrough shows that editing genes in the womb could save the lives of babies born with inherited lung diseases that currently have no cure.
Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress.
2018
Inflammation
Costa J, Zhu Y, Cox T, Fawcett P, Shaffer T +1 more
Plain English This study looked at how smooth muscle cells in the pulmonary artery react to high pressure and increased oxygen levels, which are common treatments for newborns with a serious lung condition called pulmonary hypertension. The researchers found that these cells released more inflammatory substances when exposed to high pressure and oxygen, with specific increases in nine different inflammatory markers. Additionally, a protein that is important for cell growth was found to be lower in these stressed cells.
This matters because the inflammation caused by these treatments could contribute to ongoing lung problems in babies with pulmonary hypertension.
Who this helps: This helps doctors and healthcare providers treating newborns with pulmonary hypertension.
In utero CRISPR-mediated therapeutic editing of metabolic genes.
2018
Nature medicine
Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ +12 more
Plain English Researchers used CRISPR gene-editing technology to fix faulty genes in mouse fetuses before birth, targeting genes that cause high cholesterol and a fatal liver disease called hereditary tyrosinemia type 1. The edited genes persisted and functioned properly after the mice were born—cholesterol levels dropped in one group, and the other group survived a disease that normally kills them. This proof-of-concept shows that prenatal gene editing could potentially prevent or cure certain genetic diseases before a baby is even born.
Management of Supplemental Oxygen for Infants with Persistent Pulmonary Hypertension of Newborn: A Survey.
2017
American journal of perinatology
Alapati D, Jassar R, Shaffer TH
Plain English This study looked at how different doctors who care for newborns handle oxygen treatment for babies with a condition called persistent pulmonary hypertension. Among the 492 doctors surveyed, 70% aimed for oxygen levels higher than 95%, but only 28% followed specific guidelines for adjusting oxygen levels. The differences in treatment practices show that there is no clear standard, which could affect how well these infants are treated.
Who this helps: This helps newborns with persistent pulmonary hypertension and their doctors.
Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application.
2017
American journal of respiratory cell and molecular biology
Alapati D, Morrisey EE
Plain English Researchers studied how to apply gene editing technology, specifically CRISPR/Cas9, to treat genetic lung diseases like cystic fibrosis and surfactant protein deficiency. They found that this method can successfully repair genetic mutations in animal models, which shows promise for developing new treatments in humans. This matters because existing treatment options are limited, and effective gene editing could offer a way to correct these serious lung conditions.
Who this helps: This helps patients with genetic lung diseases and their doctors by providing new treatment possibilities.
Short-term weight gain velocity in infants with congenital diaphragmatic hernia (CDH).
2017
Early human development
Gien J, Murthy K, Pallotto EK, Brozanski B, Chicoine L +8 more
Plain English This study looked at how quickly infants with congenital diaphragmatic hernia (CDH) gain weight in the hospital and how this affects their chances of survival. Researchers found that among 630 infants, those who gained weight the fastest (more than 5.9 grams per kilogram per day) had a 2.9 times higher risk of mortality, and those who gained the least weight (less than 3.1 grams per kilogram per day) had a 9.5 times higher risk compared to those with moderate weight gain (3.1 to 5.9 grams per kilogram per day). This is important because it highlights the need for better nutritional strategies to support the growth of these infants, which can ultimately improve their survival rates.
Who this helps: This helps infants with CDH and their caregivers.
Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes.
2017
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Plain English This study looked at how different breathing machine settings for newborns on extracorporeal membrane oxygenation (ECMO) affect their recovery from serious lung problems. Researchers analyzed 3,040 cases and found that 88% used conventional mechanical ventilation while 12% used high-frequency ventilation. They discovered that high-frequency ventilation was linked to longer ECMO and mechanical ventilation durations, while higher pressure settings in conventional ventilation led to shorter ECMO times but longer periods of mechanical ventilation after ECMO.
Who this helps: This information helps doctors optimize treatment for newborns with severe respiratory failure.
Skeletal dysplasia: Respiratory management during infancy.
2017
Respiratory medicine
Alapati D, Shaffer TH
Plain English The research studied how to manage breathing problems in newborns with skeletal dysplasia, a condition that affects bone and cartilage development, leading to shorter limbs and trunk. It found that these infants often face serious respiratory issues right after birth, including problems with their airways and underdeveloped lungs. This understanding is important because it helps doctors provide better care and support for these vulnerable infants, ensuring they get the right treatment early on.
Who this helps: This helps doctors and healthcare providers caring for newborns with skeletal dysplasia.
The use of mystery shopping for quality assurance evaluations of HIV/STI testing sites offering services to young gay and bisexual men.
2015
AIDS and behavior
Bauermeister JA, Pingel ES, Jadwin-Cakmak L, Meanley S, Alapati D +4 more
Plain English This study looked at how well HIV and STI testing clinics in Southeast Michigan serve young gay and bisexual men. Researchers used "mystery shoppers" to evaluate 43 clinics, scoring them on 13 aspects of service. They found that while most clinics scored positively, those focused solely on HIV testing performed better in certain areas, such as discussing safer sex practices. This matters because it shows that clinics need to improve their education and counseling on safe sex for better support of this at-risk group.
Who this helps: Young gay and bisexual men seeking HIV/STI testing and care.
Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
2014
American journal of respiratory cell and molecular biology
Alapati D, Rong M, Chen S, Hehre D, Hummler SC +1 more
Plain English Researchers studied bronchopulmonary dysplasia (BPD), a serious lung disease in preterm infants that often leads to pulmonary hypertension (PH). They discovered that using a drug called ICG001 improved lung development and reduced PH in newborn rats exposed to high oxygen levels; specifically, ICG001 increased lung growth and lowered harmful cell behaviors linked to vascular issues. This finding is important because it highlights a potential new treatment approach to help preterm infants with BPD manage their condition better.
Who this helps: This helps preterm infants affected by bronchopulmonary dysplasia and their healthcare providers.
Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
2013
American journal of respiratory cell and molecular biology
Hummler SC, Rong M, Chen S, Hehre D, Alapati D +1 more
Plain English This study looked at how a specific protein called GSK-3β affects lung damage in newborn rats exposed to high levels of oxygen, a condition that mimics what premature infants experience. The researchers found that using a drug to inhibit GSK-3β significantly reduced inflammation and improved lung development, making the lungs healthier in these rats. This is important because it suggests a new way to prevent serious lung diseases in premature babies by targeting this protein.
Who this helps: This benefits premature infants at risk of developing chronic lung diseases like bronchopulmonary dysplasia.
Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats.
2013
Pediatric research
Alapati D, Rong M, Chen S, Lin C, Li Y +1 more
Plain English This research focused on the effects of a treatment called Mesd on newborn rats suffering from lung injuries caused by too much oxygen. The study found that administering Mesd reduced harmful lung changes and high blood pressure in the lungs, with significant reductions in key indicators—some by nearly half—compared to untreated rats. This is important because it highlights LRP5/6 proteins as potential targets for future therapies to help premature babies with serious lung conditions.
Who this helps: This helps infants with bronchopulmonary dysplasia and their doctors.
Pentoxifylline and prevention of hyperoxia-induced lung -injury in neonatal rats.
2012
Pediatric research
Almario B, Wu S, Peng J, Alapati D, Chen S +1 more
Plain English This study looked at the effects of a drug called pentoxifylline (PTX) on newborn rats exposed to high levels of oxygen, which can damage their lungs. The researchers found that PTX improved survival rates from 54% to 88% and reduced lung swelling and inflammation. Additionally, PTX boosted the levels of important antioxidants and improved blood vessel formation in the lungs, which may help protect against serious lung conditions in premature babies.
Who this helps: This research benefits doctors and healthcare providers working with premature newborns at risk of lung injury.
Plain English This study looks at non-invasive ways to help newborns breathe better, especially those who are at high risk for breathing problems. Researchers found that non-invasive respiratory support could potentially reduce complications like chronic lung issues, which affect many babies who have been treated with more invasive ventilation methods. This is important because fewer complications can lead to better overall health outcomes for newborns.
Who this helps: This helps high-risk newborns and their families by improving their chances of healthier development.
American journal of respiratory cell and molecular biology
Alapati D, Rong M, Chen S, Hehre D, Rodriguez MM +2 more
Plain English This study looked at how a specific protein called connective tissue growth factor (CTGF) affects lung injury in newborn rats exposed to high levels of oxygen, which is known to contribute to a serious lung condition called bronchopulmonary dysplasia (BPD). The researchers found that when newborn rats were exposed to 90% oxygen for 14 days, it led to damaged lungs and high blood pressure in the lungs, but using a CTGF-blocking treatment improved lung development and reduced injuries. These findings show that targeting CTGF could be a new way to treat or prevent BPD in premature babies.
Who this helps: This benefits neonatologists and healthcare professionals treating premature infants.
Subcutaneous sumatriptan relieved migraine-like headache in two adolescents with aseptic meningitis.
2008
Headache
Prokhorov S, Khanna S, Alapati D, Pallimalli SL
Plain English This study looked at two teenagers who had severe headaches that felt like migraines but were actually caused by a condition called aseptic meningitis. When treated with a medication called sumatriptan, their headaches went away quickly. This is important because it shows that sumatriptan can be effective for headaches linked to meningitis, not just migraines.
Who this helps: This helps adolescents suffering from meningitis-related headaches.